Navigation Links
Warner Chilcott Announces 2008 Financial Guidance
Date:1/28/2008

ST. DAVID'S, Bermuda, Jan. 28 /PRNewswire-FirstCall/ -- Warner Chilcott Limited (Nasdaq: WCRX) announced today a view of anticipated full year 2008 results.

Total revenues for 2008 are expected to be in the range of $935 to $945 million, with the growth primarily being driven by LOESTRIN 24 FE, DORYX, FEMCON FE, and TACLONEX. Gross profit margin, as a percentage of total revenues, is anticipated to be in the range of 80% to 81% in 2008.

Total selling, general and administrative (SG&A) expenses in 2008 are anticipated to be in the range of $228 to $237 million, which reflects the previously disclosed reduction of advertising and promotional spend due to a reduction in DTC advertising in 2008 as compared to 2007. For a detailed view of the components of SG&A please refer to the summary at the end of this press release.

Total R&D spend in 2008 is anticipated to be in the range of $57 to $60 million. Included in this amount is internal R&D expense of $54 to $57 million and anticipated potential milestone payments to third parties of $3 million.

Based on the 2008 view, GAAP net income is expected to be in the range of $118 to $128 million. Cash net income in 2008 is anticipated to be $315 to $325 million. Using 251.0 million Class A shares, the Company expects cash net income per share to be in the range of $1.25 to $1.30 for the full year 2008.

References in this press release to "cash net income" mean the Company's net income adjusted for the after-tax effects of two non-cash items: amortization of intangible assets and amortization (or write-off) of deferred loan costs related to the Company's debt. Reconciliations from the Company's anticipated US GAAP results to cash net income expected results are prese
'/>"/>

SOURCE Warner Chilcott Limited
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Warner Chilcott to Present at the 2008 Wachovia Healthcare Conference
2. Warner Chilcott to Present at the 26th Annual JPMorgan Healthcare Conference
3. Warner Chilcott Reports Operating Results for the Quarter Ended September 30, 2007
4. Warner Chilcott and NexMed Sign U.S. Collaboration for Topical Alprostadil Treatment for Erectile Dysfunction
5. Virginia Faith Leaders Call on Senators Webb & Warner to Cosponsor Legislation to Protect Kids from Tobacco
6. WellPoint Announces Appearance at Upcoming Conference
7. OPKO Health Announces Changes to Board of Directors
8. NuVasive Announces Preliminary Unaudited Full Year 2007 Financial Results
9. IDEXX Laboratories Announces Fourth Quarter Results
10. U.S. Department of Labor Announces $1.25 Million to North Carolina to Help Trade-Affected Workers Pay for Health Insurance
11. Acura Pharmaceuticals, Inc. Announces Appointment of George K. Ross as Director
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2015)... 28, 2015 The USC Verdugo Hills Hospital ... management for a decade with a current average healing rate ... USC and Wound Care Advantage to provide in-patient wound care. ... for a drop in the rate of hospital-acquired pressure ulcers ... is a complex undertaking that can frighten patients and caregivers ...
(Date:5/28/2015)... Falls Church, VA (PRWEB) May 28, 2015 ... Roadmap to the 351(k) Application Process, **FDAnews Webinar**, ... p.m. EDT, [http://www.fdanews.com/BiosimilarsApproval , On June ... and expertise of two leading intellectual property attorneys ... the webinar Success Strategies for Biosimilars Approval: A ...
(Date:5/28/2015)... 2015 Three years ago, Dr. Jeffrey Gosin ... Shore Vascular & Vein Center! Dr. Gosin’s center ... It is his mission to provide the highest quality care ... , Dr. Jeffrey Gosin is Board Certified in Surgery and ... Pennsylvania and Jefferson Medical College. He completed a General Surgery ...
(Date:5/28/2015)... (PRWEB) May 28, 2015 Ross A. ... surgeon , has hired Teresa Beard as the new ... her role, Beard will oversee all marketing and promotional ... of experience leading teams and developing compelling marketing strategies ... and Body Specialists, Beard served as guest communication manager ...
(Date:5/28/2015)... Boston Celtics Legend and Basketball Hall of ... Board of Directors members, will be hosting their 34th ... 4-7. For the past 34 years, the Havlicek’s have ... for children by bringing together friends, families, and celebrities ... Havlicek Celebrity Fishing Tournament will be held from June ...
Breaking Medicine News(10 mins):Health News:USC Verdugo Hills Hospital Wound Care Team Provides Outstanding Healing Results 2Health News:FDAnews Announces — Success Strategies for Biosimilars Approval: A Roadmap to the 351(k) Application Process Webinar, June 23, 2015 2Health News:FDAnews Announces — Success Strategies for Biosimilars Approval: A Roadmap to the 351(k) Application Process Webinar, June 23, 2015 3Health News:Dr. Jeffrey Gosin is Celebrating Three Years at his Somers Point Location! 2Health News:Dr. Jeffrey Gosin is Celebrating Three Years at his Somers Point Location! 3Health News:Clevens Face and Body Specialists Welcomes Teresa Beard as Marketing Director 2Health News:The Genesis Foundation Prepares for Their Final Annual John Havlicek Celebrity Fishing Tournament 2
... People with a serious heart condition called nonischemic ... they have a device called a cardioverter-defibrillator implanted ... 460 patients with severe cardiomyopathy to receive either ... beta-blockers, or standard treatment plus an implanted defibrillator. ...
... Acute liver failure is the loss of liver function ... Standard treatment consists of intensive supportive care intended to ... recover spontaneously // or a donor organ becomes available ... unless they receive a liver transplant. ,A bioartificial ...
... to look for all the ways a drug called orlistat, ... medication, which is known to keep the body from absorbing ... keeps prostate cancer cells in check. ,Researchers say ... of fatty acid synthase, an enzyme that turns the carbohydrates ...
... light on the theory that aging is associated with the ... gene responsible for shortening the ends of chromosomes is inherited ... length of the end of the chromosomes, known as telomeres, ... of families living in northern Belgium. Telomere length was found ...
... shows there may be reason to believe we have a ... may block unwanted memories. ,Researchers from Stanford University studied ... given 36 pairs of unrelated words and asked to remember ... pairs into three sets of 12. Participants were asked to ...
... were when you heard about the World Trade Center attack? ... But why? A new study finds lasting memories are formed ... kinase C.// ,Researchers in New Orleans studied ... discovered that with only one exposure at mating, the mice ...
Cached Medicine News:
(Date:5/28/2015)... , May 28, 2015 AlloSource ... cartilage, cellular, bone, skin and soft-tissue allografts for ... advance patient healing, today announced that AlloWrap® DS, ... moved to the high-cost reimbursement category. ... doctors and their patients," said Kimberly French ...
(Date:5/28/2015)... 2015 Isis Pharmaceuticals, Inc. (NASDAQ: ISIS ... , Thursday, June 4 at 1:00 p.m. ET / ... on the Internet.  Simply log onto our website listed ... live event, a replay of the webcast will be ... ABOUT ISIS PHARMACEUTICALS, INC. Isis is exploiting ...
(Date:5/28/2015)... Calif. , May 28, 2015  CytomX, a ... cancer, today announced that Sean McCarthy , D. ... Jefferies 2015 Global Healthcare Conference in ... on Tuesday, June 2, 2015. Dr. McCarthy will provide ... Precision cancer immunotherapy and Probody drug conjugate programs. ...
Breaking Medicine Technology:AlloSource Announces Milestone In Reimbursement For AlloWrap DS 2Webcast Alert: Akcea Therapeutics Conference Call 2Webcast Alert: Akcea Therapeutics Conference Call 3
... , NEW YORK, Nov. 30 ... available in its catalogue: , Operating Tables - ... , Operating tables are primarily used to keep the ... to conduct the surgical procedure and, if necessary, enable ...
... ... announces that a new market research report is ... Devices Investment Opportunities, Analysis and Forecasts to 2015 ... Devices Investment Opportunities, Analysis and Forecasts to 2015 ...
Cached Medicine Technology:Reportlinker Adds Operating Tables - A World Market Review 2Reportlinker Adds Operating Tables - A World Market Review 3Reportlinker Adds Operating Tables - A World Market Review 4Reportlinker Adds Operating Tables - A World Market Review 5Reportlinker Adds Europe Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015 2Reportlinker Adds Europe Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015 3Reportlinker Adds Europe Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015 4Reportlinker Adds Europe Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015 5Reportlinker Adds Europe Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015 6Reportlinker Adds Europe Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015 7Reportlinker Adds Europe Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015 8Reportlinker Adds Europe Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015 9Reportlinker Adds Europe Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015 10Reportlinker Adds Europe Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015 11Reportlinker Adds Europe Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015 12Reportlinker Adds Europe Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015 13Reportlinker Adds Europe Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015 14Reportlinker Adds Europe Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015 15Reportlinker Adds Europe Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015 16
Indications For Usage: ,Pediatric (recommended tidal volume 70-250ml), single patient use on anesthetized patients and respiratory care patients who require a breathing circuit. The product is intend...
Indications For Usage: ,Adult (recommended tidal volume >150ml), single patient use on anesthetized patients and respiratory care patients who require a breathing circuit. The product is intended to...
... The Portex® Thermovent® T helps provide protection ... It is small and extremely lightweight making it ... adults. With a high rate of heat and ... secretion retention., ,All HMEs and filters have ...
... helps provide protection to the exposed airway of ... lightweight making it ideal for active young children ... of heat and moisture recovery, it ensures patient ... and filters have ISO standard tapered ends to ...
Medicine Products: